India oxcarbazepine
market is expected to grow at a steady rate during the forecast period. Oxcarbazepine
drug is an anticonvulsant used in the treatment of epilepsy. This drug API is
either used alone or along with other drugs for treating partial seizures which
is expected to rev up the market growth through FY2027. Additionally,
supportive government policies and improving healthcare infrastructure are some
other reasons that are expected to create lucrative opportunities for the
market growth over the next few years.
The India oxcarbazepine
market is segmented based on source, form, distribution channel, application,
end user, company and region. Based on source, the market can be split into
in-house and contract manufacturing organizations. Out of which, the in-house
segment dominated the market until FY2021 owing to in house production
preference by the major market players. The contract manufacturing
organizations segment is expected to witness significant growth during the
forecast period on account of increased outsourcing activities by the companies
in order to focus on their R&D activity and expansion plans. Additionally,
contract manufacturing organizations offer competitive pricing and can provide
bulk orders in lesser duration. This is further projected to contribute to the
segmental growth in the coming years.
The major players
operating in the India oxcarbazepine market are Sun Pharmaceuticals Industries
Ltd., Intas Pharmaceutical Ltd., Sunrise Remedies Pvt. Ltd., Cipla Limited, Zydus
Cadila Healthcare Ltd., Nicholas Piramal India Ltd., Torrent Pharmaceuticals
Ltd., Macleods Pharmaceuticals Ltd., Consern Pharma Pvt. Ltd., Glenmark Lifesciences Ltd. and
others. Major companies are developing advanced technologies, receiving
approvals from regulatory bodies and launching new products in order to stay
competitive in the market. Other competitive Go-to-Market strategies include
mergers & acquisitions, research collaborations, customer focus approach
and new product developments.
Years considered for
this report:
Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year:
FY2022
Forecast Period: FY2023–FY2027
Objective of the Study:
- To analyze and estimate the market size of
India oxcarbazepine market from FY2017 to FY2020.
- To estimate and forecast the market size of
India oxcarbazepine market from FY2021 to FY2027 and growth rate until FY2027.
- To classify and forecast India oxcarbazepine market
based on source, form, distribution channel, application, end user,
company and regional distribution.
- To identify dominant region or segment in the
India oxcarbazepine market.
- To identify drivers and challenges for India oxcarbazepine
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in
India oxcarbazepine market.
- To identify and analyze the profile of leading
players operating in India oxcarbazepine market.
- To identify key sustainable strategies adopted
by market players in India oxcarbazepine market.
Click here to download the sample
TechSci Research performed
both primary as well as exhaustive secondary research for this study.
Initially, TechSci Research sourced a list of manufacturers across the globe.
Subsequently, TechSci Research conducted primary research surveys with the
identified companies. While interviewing, the respondents were also enquired
about their competitors. Through this technique, TechSci Research could include
the manufacturers which could not be identified due to the limitations of
secondary research. TechSci Research analyzed the manufacturers, distribution
channels and presence of all major players across the globe.
TechSci Research calculated the market size of India oxcarbazepine market using bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also
studied by TechSci Research.
Key Target Audience:
- Oxcarbazepine manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to oxcarbazepine
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this
report, India oxcarbazepine market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- India Oxcarbazepine Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Oxcarbazepine Market, By Form:
- India Oxcarbazepine Market, By Distribution
Channel:
- India Oxcarbazepine Market, By Application:
- Epilepsy
- Neuropathic Pain
- Seizures
- Others
- India Oxcarbazepine Market, By End User:
- India Oxcarbazepine Market, By Region:
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in India oxcarbazepine market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India oxcarbazepine market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]